Cardio-vascular
Refine Search
Generics
US pharma giant Pfizer and the Scripps Research Institute have accused generics company Dexcel Pharma Technologies of patent infringement. 14 August 2023
Pharmaceutical
CNX Therap buys Clinigen brands to expand hospital-injectable portfolio 11 August 2023
Biotechnology
ADARx Pharma nabs $200 million financing 9 August 2023
Pharmaceutical
Shares in Danish diabetes giant Novo Nordisk have risen sharply after positive topline data were announced from the SELECT cardiovascular outcomes trial. 8 August 2023
Biotechnology
Dyslipidemia market to grow to $15.53 billion in 2032 across 7MM 8 August 2023
Biotechnology
Privately-held UK biotech Evox Therapeutics has announced a research collaboration and option agreement with the Icahn School of Medicine at Mount Sinai (Icahn 4 August 2023
Biotechnology
The week in pharma: action, reaction and insight – week to July 28, 2023 30 July 2023
Biotechnology
Shares in BioCardia, a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, closed nearly 50% lower on 25 July 2023
Biotechnology
Roche partners with Alnylam on RNAi therapeutic zilebesiran 24 July 2023
Biotechnology
The week in pharma: action, reaction and insight – week to July 21, 2023 23 July 2023
Pharmaceutical
Shares in Novartis closed 5% higher on Tuesday after the Swiss pharma major announced its second-quarter financial results and other updates for shareholders. 18 July 2023
Pharmaceutical
BridgeBio releases much awaited Phase III results for its acoramidis 17 July 2023
Pharmaceutical
Generic erosion will see atrial fibrillation market decline 17 July 2023
Generics
Global drugmakers continue to defend rights for their original drugs in Russia 12 July 2023
Pharmaceutical
Novartis to appeal US Entresto patent decision 8 July 2023
Pharmaceutical
Bristol Myers Squibb has announced that the European Commission (EC) has approved Camzyos (mavacamten) to treat symptomatic (New York Heart Association, NYHA, c 27 June 2023
Biotechnology
Talaris Therapeutics and Tourmaline Bio to merge 22 June 2023
Pharmaceutical
An ancient Egyptian medicament, developed by a family-run Slovakian firm, has been approved to help prevent heart attacks and strokes in the USA. 21 June 2023
Generics
FTC files Amicus Brief in Bystolic antitrust litigation 21 June 2023
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze